COPD News

Patients hospitalized for a COPD exacerbation who participated in pulmonary rehabilitation within 90 days of discharge had a lower rate of readmission within 1 year, according to new data.

Nuvaira Inc. announced that its targeted lung denervation system for patients with COPD has been designated as a breakthrough device by the FDA.

In a CDC study, total annualized medical expenditures in U.S. workers from 2011 to 2015 were $7 billion for asthma-related events and $5 billion for COPD-related events, according to data published in Morbidity and Mortality Weekly Report.

The Healio Editors have compiled a list of the most-read pulmonology news published in June.

Patients with moderate to severe COPD traveling to high altitude experienced improvements in hypoxemia, breathing disturbances and other adverse health effects with nocturnal oxygen therapy, according to data published in JAMA Network Open.

People with small airways relative to the size of their lungs may have a lower breathing capacity and, consequently, increased risk for COPD, even if they do not smoke or have other risk factors, according to a study published in JAMA.

Triple inhaled therapy with twice-daily budesonide, at two doses, glycopyrrolate and formoterol reduced the rate of moderate or severe COPD exacerbations compared with two dual-combination therapies, according to data from the ETHOS trial.

Adults working in certain industries and occupations, and those currently not working, have higher risk for asthma-COPD overlap mortality, according to new data published in Morbidity and Mortality Weekly Report.

Healio Pulmonology has you covered. The Editors have compiled a list of popular articles posted on Healio Pulmonology in May.

Older adults with certain chronic conditions were significantly more likely to have severe tooth loss compared with adults who did not suffer from chronic conditions, according to an analysis published in Morbidity and Mortality Weekly Report.